Alexander Kuklin
Vice President, BioPharma Partnerships Predicine
Seminars
Tuesday 21st July 2026
Tumor-Naïve & Blood-Informed MRD Solutions for Global Oncology Drug Development
3:00 pm
- Tumor-naïve, methylation-based MRD solutions for broad clinical applications
- Personalized, baseline-informed MRD solutions leveraging baseline tissue, blood, or urine samples
- Harmonized tissue and liquid biopsy testing solutions supporting global oncology clinical trials across the U.S. and China
